CELL AND GENE THERAPY INSIGHTS

The Cell & Gene Therapy Manufacturing Pathway: Part 1

March 2016
The Cell & Gene Therapy Manufacturing Pathway: Part 1

Foreword

Spotlight on the cell & gene therapy manufacturing pathway

Spotlight on the cell & gene therapy manufacturing pathway

Chris Mason, Elisa Manzotti
21 March 2016
Read

Expert Insight

Cell and gene therapy manufacturing: the necessity for a cost-based development approach

Cell and gene therapy manufacturing: the necessity for a cost-based development approach

S Callens, J Hasan, R McCoy et al.
21 March 2016
Read
Drivers and methodologies for making cell therapy process changes

Drivers and methodologies for making cell therapy process changes

Gregory Russotti
21 March 2016
Read
Centralized or decentralized manufacturing? Key business model considerations for cell therapies

Centralized or decentralized manufacturing? Key business model considerations for cell therapies

Nicholas Medcalf
21 March 2016
Read
Evolving product attributes through the lens of MSC translation

Evolving product attributes through the lens of MSC translation

Robert Deans
21 March 2016
Read

Innovator Insight

Translational cell & gene therapy collaborations: accelerating time to market

Translational cell & gene therapy collaborations: accelerating time to market

Cindy Collins
21 March 2016
Read

Perspective

Toward a scalable and consistent manufacturing process for the production of human MSCs

Toward a scalable and consistent manufacturing process for the production of human MSCs

Qasim Rafiq
21 March 2016
Read
Key considerations in optimizing pluripotent stem cell bioprocessing

Key considerations in optimizing pluripotent stem cell bioprocessing

Iwan Roberts
21 March 2016
Read